IRIS Accounts Production v26.1.0.640 12167965 Board of Directors 1.9.24 31.8.25 31.8.25 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 Ordinary C 1.00000 1889 502 45192 12786 30974 14173 12329 1889 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh121679652024-08-31121679652025-08-31121679652024-09-012025-08-31121679652023-08-31121679652023-09-012024-08-31121679652024-08-3112167965ns15:EnglandWales2024-09-012025-08-3112167965ns14:PoundSterling2024-09-012025-08-3112167965ns10:Director12024-09-012025-08-3112167965ns10:PrivateLimitedCompanyLtd2024-09-012025-08-3112167965ns10:SmallEntities2024-09-012025-08-3112167965ns10:AuditExempt-NoAccountantsReport2024-09-012025-08-3112167965ns10:SmallCompaniesRegimeForDirectorsReport2024-09-012025-08-3112167965ns10:SmallCompaniesRegimeForAccounts2024-09-012025-08-3112167965ns10:FullAccounts2024-09-012025-08-3112167965ns10:OrdinaryShareClass12024-09-012025-08-3112167965ns10:OrdinaryShareClass22024-09-012025-08-3112167965ns10:OrdinaryShareClass32024-09-012025-08-3112167965ns10:Director1412024-08-3112167965ns10:Director1412023-08-3112167965ns10:Director1412024-09-012025-08-3112167965ns10:Director1412023-09-012024-08-3112167965ns10:Director1412025-08-3112167965ns10:Director1412024-08-3112167965ns5:CurrentFinancialInstruments2025-08-3112167965ns5:CurrentFinancialInstruments2024-08-3112167965ns5:ShareCapital2025-08-3112167965ns5:ShareCapital2024-08-3112167965ns5:RetainedEarningsAccumulatedLosses2025-08-3112167965ns5:RetainedEarningsAccumulatedLosses2024-08-3112167965ns10:RegisteredOffice2024-09-012025-08-3112167965ns5:FurnitureFittings2024-08-3112167965ns5:ComputerEquipment2024-08-3112167965ns5:FurnitureFittings2024-09-012025-08-3112167965ns5:ComputerEquipment2024-09-012025-08-3112167965ns5:FurnitureFittings2025-08-3112167965ns5:ComputerEquipment2025-08-3112167965ns5:FurnitureFittings2024-08-3112167965ns5:ComputerEquipment2024-08-3112167965ns5:WithinOneYearns5:CurrentFinancialInstruments2025-08-3112167965ns5:WithinOneYearns5:CurrentFinancialInstruments2024-08-3112167965ns10:OrdinaryShareClass12025-08-3112167965ns10:OrdinaryShareClass22025-08-3112167965ns10:OrdinaryShareClass32025-08-3112167965ns10:Director112024-08-3112167965ns10:Director112023-08-3112167965ns10:Director112024-09-012025-08-3112167965ns10:Director112023-09-012024-08-3112167965ns10:Director112025-08-3112167965ns10:Director112024-08-31
REGISTERED NUMBER: 12167965 (England and Wales)















Unaudited Financial Statements for the Year Ended 31st August 2025

for

NJL Healthcare Limited

NJL Healthcare Limited (Registered number: 12167965)






Contents of the Financial Statements
for the Year Ended 31st August 2025




Page

Balance Sheet 1

Notes to the Financial Statements 2


NJL Healthcare Limited (Registered number: 12167965)

Balance Sheet
31st August 2025

31.8.25 31.8.24
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 4,589 1,586

CURRENT ASSETS
Debtors 5 39,972 36,806
Cash at bank 27,306 5,347
67,278 42,153
CREDITORS
Amounts falling due within one year 6 8,571 8,780
NET CURRENT ASSETS 58,707 33,373
TOTAL ASSETS LESS CURRENT
LIABILITIES

63,296

34,959

PROVISIONS FOR LIABILITIES 872 350
NET ASSETS 62,424 34,609

CAPITAL AND RESERVES
Called up share capital 7 102 102
Retained earnings 62,322 34,507
SHAREHOLDERS' FUNDS 62,424 34,609

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st August 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st August 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 22nd April 2026 and were signed on its behalf by:





Dr N J Lee - Director


NJL Healthcare Limited (Registered number: 12167965)

Notes to the Financial Statements
for the Year Ended 31st August 2025

1. COMPANY INFORMATION

NJL Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 12167965

Registered office: 10-12 Mount Street
Manchester
Greater Manchester
M2 5NT

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue from the provision of professional services is recognised on delivery of the service.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Tangible fixed assets are included at cost less depreciation and impairment. Depreciation has been computed to write off the cost of tangible fixed assets over their expected useful life.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

NJL Healthcare Limited (Registered number: 12167965)

Notes to the Financial Statements - continued
for the Year Ended 31st August 2025

4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1st September 2024 3,605 - 3,605
Additions - 5,205 5,205
At 31st August 2025 3,605 5,205 8,810
DEPRECIATION
At 1st September 2024 2,019 - 2,019
Charge for year 901 1,301 2,202
At 31st August 2025 2,920 1,301 4,221
NET BOOK VALUE
At 31st August 2025 685 3,904 4,589
At 31st August 2024 1,586 - 1,586

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.8.25 31.8.24
£    £   
Trade debtors 27,642 36,806
Directors' current accounts 12,330 -
39,972 36,806

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.8.25 31.8.24
£    £   
Tax 7,491 6,108
Directors' current accounts - 1,889
Accrued expenses 1,080 783
8,571 8,780

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.8.25 31.8.24
value: £    £   
100 Ordinary A £1 100 100
1 Ordinary B £1 1 1
1 Ordinary C £1 1 1
102 102

The A Shares confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

The B, and C Shares do not confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

The A, B, and C Shares rank pari passu in respect of dividend and capital distribution rights.

NJL Healthcare Limited (Registered number: 12167965)

Notes to the Financial Statements - continued
for the Year Ended 31st August 2025

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31st August 2025 and 31st August 2024:

31.8.25 31.8.24
£    £   
Dr N J Lee and Dr N J Lee
Balance outstanding at start of year (1,889 ) (502 )
Amounts advanced 45,192 12,786
Amounts repaid (30,974 ) (14,173 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 12,329 (1,889 )

9. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is Dr N J Lee by virtue of holding 100% of the voting share capital.